Legalization Part Deux: What to Expect From Marijuana Stocks Like Aurora Cannabis (TSX:ACB)

It’s déjà-vu. Here we are in early September, and the cannabis industry is on the cusp of another significant macro event. The legalization of cannabis edibles is expected to come no later than October 17, 2019. If the date sounds familiar, it should. It is exactly a year to the day Canada legalized the sale of recreational marijuana. Estimates vary…

Read More

Investors: Is the Time Ripe to Bet on Cannabis Once Again?

Several cannabis stocks have created significant investor wealth over the years. Stocks such as Aurora Cannabis, Canopy Growth, Hexo, and Aphria have generated staggering returns over the years. Cannabis stocks gained tremendous value just before legalization in October 2018. While ACB rose 90% between December 2017 and October 2018, Canopy was up 97% between December 2017 and September 2018. Hexo…

Read More

Marijuana Stock Investors: Don’t Miss Out on This IPO

Would the initial public offering of Breath of Life International be the most explosive IPO when the company finally lists on the TSX? Israel’s largest medical cannabis producer is known more as BOL Pharma in its home country. You shouldn’t miss on out on this marijuana IPO, as the company could be the global leader in medical cannabis. As of…

Read More

Why CannTrust (TSX:TRST) Shares Could Be Headed Even Lower

CannTrust Holdings Inc (TSX:TRST)(NYSE:CTST) continues getting hammered as the share price has fallen more than $10 from where it was earlier in the year. The problem for CannTrust investors that may be hoping for some sort of a miracle is that things could be about to get even worse for the stock. Recently, The Globe and Mail reported that due to the…

Read More

Will September Be a Better Month for Pot Stocks?

Last month was not a good one for the cannabis industry. Still reeling from scandals and poor earnings, even Canopy Growth (TSX:WEED)(NYSE:CGC) fell to levels not seen in a long time, as it lost more than 25% of its share price in just one month. Rival Aurora Cannabis was also down more than 9%. One of the lone bright spots was Aphria, which benefited…

Read More

Go Long on “Big Cannabis” and Ignore Edibles?

Unless you’re a momentum trader looking for some quick upside, the legalization of edibles next month should be given a wide berth by long-term investors. Instead, a low-risk, long-range position in a big player such as Canopy Growth (TSX:WEED)(NYSE:CGC) may seem the wisest option for newcomers looking to gain upside from the cannabis industry. The rebooted cannabis space may be…

Read More

Here’s Why Aurora Cannabis (TSX:ACB) Stock Is a Bargain

Aurora Cannabis (TSX:ACB)(NYSE:ACB) stock has dropped 32.6% over the past three months as of close on August 29. Cannabis stocks have been hit with turbulence since the middle of spring, and Aurora has not been spared. Sales have disappointed in 2019 as we approach the one-year anniversary of the legalization of recreational cannabis. Canada is set to move forward with…

Read More

Cannabis Investors: 2 Stocks That Could Dominate Retail

It’s getting close to the one-year mark since cannabis has been legalized, and a lot has changed since then. The excitement in the industry has definitely cooled with many stocks struggling over the past few months. However, that doesn’t mean that good returns can’t still be made. With supply issues improving and more pot shops up and running, the next…

Read More

2 Cannabis Companies With Huge Potential That You May Have Never Heard of

Up until now, the major cannabis companies that have gotten the headlines have been large licensed producers that were expected to dominate the market. Unfortunately, that hasn’t panned out yet, as the government is slow to implement the legalization of cannabis fully. From the government’s point of view, this move is prudent, as the government wants to make sure it…

Read More

Canopy Growth (TSX:WEED) Stock: Should You Buy the Dip?

Cannabis stocks were riding high, as we moved into the spring of 2019. The glow had returned after a rough post-legalization dip for the sector. Broader market turbulence has historically had a strong impact on cannabis stocks, and the late 2018 correction was no different. Unfortunately, this momentum has not lasted. In the middle of spring, I’d warned investors that…

Read More